125 related articles for article (PubMed ID: 6886987)
21. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
Menke G; Schnellhammer R; Rietbrock N
Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate.
Pipili-Synetos E; Papageorgiou A; Sakkoula E; Sotiropoulou G; Fotsis T; Karakiulakis G; Maragoudakis ME
Br J Pharmacol; 1995 Sep; 116(2):1829-34. PubMed ID: 8528567
[TBL] [Abstract][Full Text] [Related]
23. Polarographic determination of isosorbide dinitrate.
Turner WR; Lenkiewicz RS
J Pharm Sci; 1976 Jan; 65(1):118-21. PubMed ID: 1255415
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of human aldehyde dehydrogenase by isosorbide dinitrate.
Mukerjee N; Pietruszko R
J Biol Chem; 1994 Aug; 269(34):21664-9. PubMed ID: 8063809
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations].
Chasseaud LF; Taylor T; Major RM; Taylor IW; Luckow V; Darragh A; Lambe RF
Arzneimittelforschung; 1983; 33(9):1298-301. PubMed ID: 6685511
[TBL] [Abstract][Full Text] [Related]
26. Determination of the two mononitrate metabolites of isosorbide dinitrate in human plasma and urine by gas chromatography with electron-capture detection.
Sioufi A; Pommier F
J Chromatogr; 1984 Jan; 305(1):95-103. PubMed ID: 6707157
[TBL] [Abstract][Full Text] [Related]
27. Quantitative determination of isosorbide dinitrate and two metabolites in plasma.
Chin DA; Prue DG; Michelucci J; Kho BT; Warner CR
J Pharm Sci; 1977 Aug; 66(8):1143-5. PubMed ID: 894502
[TBL] [Abstract][Full Text] [Related]
28. Effects of isosorbide-5-mononitrate and isosorbide-2-mononitrate on the contractile and electrical activity and on the content of cyclic nucleotides in isolated heart muscles of the guinea-pig and dog.
Atanassova R; Spassov G; Balansky R; Boev K
J Pharm Pharmacol; 1992 Aug; 44(8):663-6. PubMed ID: 1359091
[TBL] [Abstract][Full Text] [Related]
29. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
30. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
31. Determination of the partitioning, stability, and metabolite formation of isosorbide dinitrate in human and rat blood using an improved gas-liquid chromatographic assay.
Morrison RA; Fung HL
J Chromatogr; 1984 Jun; 308():153-64. PubMed ID: 6430939
[TBL] [Abstract][Full Text] [Related]
32. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
33. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
[TBL] [Abstract][Full Text] [Related]
34. Influence of standard and nicotine-reduced cigarette smoke on plasma concentrations of isosorbide dinitrate and its metabolites in rats.
Gomita Y; Furuno K; Araki Y
J Pharm Pharmacol; 1991 Nov; 43(11):811-2. PubMed ID: 1686914
[TBL] [Abstract][Full Text] [Related]
35. Solid-phase extraction of isosorbide dinitrate and two of its metabolites from plasma for gas chromatographic analysis.
Gremeau I; Sautou V; Pinon V; Rivault F; Chopineau J
J Chromatogr B Biomed Appl; 1995 Mar; 665(2):399-403. PubMed ID: 7795821
[TBL] [Abstract][Full Text] [Related]
36. Fate of orally given isosorbide dinitrate in man: factors of variability.
Bogaert MG; Rosseel MT
Z Kardiol; 1983; 72 Suppl 3():11-3. PubMed ID: 6141676
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].
Abshagen U; Spörl-Radun S; Betzien G; Kaufmann B; Endele R
Med Welt; 1981 Apr; 32(14A):508-16. PubMed ID: 7242310
[No Abstract] [Full Text] [Related]
38. Single administration of atenolol does not influence the kinetics of orally given isosorbide dinitrate.
Bogaert MG; Rosseel MT; Bruyneel K
Int J Clin Pharmacol Res; 1983; 3(6):491-3. PubMed ID: 6678835
[TBL] [Abstract][Full Text] [Related]
39. Influence of exercise on plasma concentrations of isosorbide dinitrate.
Bogaert MG; Lefebvre RA; Rosseel MT; Bouckaert J
Eur J Clin Pharmacol; 1988; 35(2):213-5. PubMed ID: 3191942
[TBL] [Abstract][Full Text] [Related]
40. Metabolic fact of 14C-isosorbide 5-mononitrate in humans.
Wood SG; John BA; Chasseaud LF; Major RM; Forrest ME; Bonn R; Darragh A; Lambe RF
Arzneimittelforschung; 1984; 34(9):1031-5. PubMed ID: 6542370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
